Clinical Trials Logo

Clinical Trial Summary

Many recent randomised multi-centre trials have used the AOS and the involvement of the French-speaking population is limited by the absence of a French version. The goal of our study was to develop a French version and validate the psychometric properties to assure equivalence to the English original.


Clinical Trial Description

Power and sample size calculation The required number of patients has been estimated based on qualities to assess. The reproducibility (test-retest) of the questionnaire is one of the main properties and assess the lower acceptable limit is .85. However, knowing that the reproducibility of the English version was .97, the investigators estimated that the French version would be at least .90. A sample of 10 patients would be sufficient to obtain a power of 99% with a reproducibility of .901,9. Regarding validity, the investigators wish to obtain a statistically significant correlation with the three selected tests. The investigators hypothesized that the lowest correlation between the AOS-Fr and the SF-36 questionnaire would provide the lowest correlation, because the SF-36 is not specific to ankle OA. By estimating an average correlation of .50, 30 patients are required to obtain a significant correlation with a power of 80% and p < .051,9.

Translation The study was approved by a local ethics committee (protocol #09-130). Following the guidelines for the cross cultural adaptation process written by the American Association of Orthopaedic Surgeons (AAOS) in 2000, the translation was performed using this six-step process 2: 1) Initial translation; 2) Synthesis; 3) Back translation; 4) Expert committee; 5) Test of the Pre-final version; and 6) Submission of document to the developer. For the "Initial translation", two independent translators whose mother tongue was French translated the scale from English to French. The second step of "Synthesis" required these two translators to meet, discuss and compose a synthesised version of the AOS. Two independent translators, blind to the original scale, whose mother tongue was English, translated the synthesised version back to English. An "Expert committee" composed of a linguist, two orthopaedic surgeons and the four translators revised the whole process and consolidated the pre-final version. The "Test of the Pre-final version" was performed using 60 subjects, with no ankle osteoarthritis, who answered the questionnaire and evaluated their comprehension of each item. From the data collected in this step, some sections of the test were changed to improve comprehension and readability. For the final step the investigators submitted the corrected version to Dr. Charles Saltzman, the developer of the English version, who approved its translation and use (Supplementary data 1).

Evaluation of psychometric properties In order to validate the use of the French AOS version, the investigators set out to evaluate the psychometric properties of the test on ankle osteoarthritis patients using the same process as the original study validating the English version of the AOS 6. Patients with isolated ankle degenerative changes at the orthopaedic outpatient clinic of the Centre Hospitalier Universitaire de Sherbrooke (CHUS) were included. To be included, patients had to consider French as their mother tongue and be able to read and write in French. Patients under 18 years old and those with additional foot and/or ankle pathologies were excluded.

At the first visit, socio-demographic data (age, sex, BMI, occupation) and pertinent past medical history (Diabetes, neuropathy, ankle or foot fractures)) were collected and patients were asked to perform single heel lift tests of both affected and unaffected side. The participants completed three questionnaires: AOS-French version, SF-36, and WOMAC. Criterion validity was assessed by comparing the AOS to the WOMAC and the SF-36 scores. Construct validity was established by the examination of the correlation between the AOS scores and the single heel lift test. Finally, to measure test-retest reliability, the patient was asked to complete the AOS a second time and a small questionnaire detailing any modification to the treatment (shoes, orthotics, medication, surgery, injection) one week following the first visit and return it by mail. Any modification to their treatment between the completion of the two AOS questionnaires would nullify the test-retest reliability, so these patients would be excluded in the analysis. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02508233
Study type Observational
Source Université de Sherbrooke
Contact
Status Completed
Phase N/A
Start date September 2009
Completion date January 2015

See also
  Status Clinical Trial Phase
Completed NCT01504438 - Prospective Randomized Evaluation of a Two and Three Piece Total Ankle Replacement N/A
Active, not recruiting NCT03440008 - Improving the Detection, Classification and Treatment of Misaligned Arthritic Ankles
Active, not recruiting NCT04405297 - A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells
Completed NCT01760577 - Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis N/A
Active, not recruiting NCT04998162 - Injections of SVF in Ankle Osteoarthritis N/A
Completed NCT03356951 - Gait Analysis Following Total Ankle Replacement and Subtalar Fusion N/A
Completed NCT02489188 - Gait Asymmetry Assessed Using Portable Gait Analysis System
Completed NCT01986244 - Total Ankle Replacement for Ankle Arthritis
Withdrawn NCT05562154 - Lateral Approach Versus Anterior Approach in Total Ankle Replacement N/A
Active, not recruiting NCT03567187 - Cryoneurolysis for Improvements in Pain, ADL and QOL in Patients With Ankle Osteoarthritis N/A
Completed NCT05868759 - Assessment of Preoperative and Postoperative Ankle Kinematics N/A
Recruiting NCT06193057 - Comparison of Customized and Standard Total Ankle Prostheses N/A
Recruiting NCT06028763 - Development of Biomedical Technology for the Treatment of Ankle Cartilage Using Injectable Biocomposite Hydrogel N/A
Completed NCT04022928 - A Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle OA N/A
Not yet recruiting NCT03573245 - Tranexamic Acid in Major Orthopedic Surgery: Comparison of 3 Dosage Regimen
Active, not recruiting NCT02629731 - Orthotic Dose Response Study N/A
Recruiting NCT03157141 - Ankle Osteoarthritis N/A
Active, not recruiting NCT03524729 - Do Rocker Bottom Shoes and Ankle-Foot Orthoses Reduce Pain and Improve Mobility for Ankle Osteoarthritis Patients N/A
Completed NCT03711747 - Indications for Osteochondral Allograft Transplantation
Completed NCT04312373 - Efficacity of a Rigid Ankle Foot Orthosis for Persons With Ankle Osteoarthritis